Open AccessExpression and Clinical Value of LncRNA GAPLINC in Esophageal Squamous Cell Carcinoma
Author(s) -
Peng Wang,
Song Yang,
Shengbin Dai,
Qingtao Ni,
Huilan Liu,
Lei Yu,
Kai Lü,
Gaohua Han,
Junxing Huang
Publication year - 2021
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s299394
Subject(s) - flow cytometry , gene silencing , cell , cancer research , cell culture , cell growth , apoptosis , cell migration , long non coding rna , biology , microbiology and biotechnology , rna , gene , biochemistry , genetics
The long noncoding RNA (lncRNA) GAPLINC, or gastric adenocarcinoma predictive long intergenic ncRNA, plays a carcinogenic role in a variety of different tumor types. There is limited information regarding the biological function of GAPLINC in the development of esophageal squamous cell carcinoma (ESCC).